1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with n-vinyl-2-pyrrolidinone in 2 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (n-vinyl-2-pyrrolidinone) | Trials (n-vinyl-2-pyrrolidinone) | Recent Studies (post-2010) (n-vinyl-2-pyrrolidinone) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 7,533 | 228 | 2,213 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al-Lamee, KG; Bamford, CH; Middleton, IP | 1 |
Casale, TB; Erger, RA; Rozell, MD | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and n-vinyl-2-pyrrolidinone
Article | Year |
---|---|
Polymeric inhibitors of platelet aggregation. II. Copolymers of dipyridamole and related drugs with N-vinylpyrrolidone.
Topics: Adenosine Diphosphate; Dipyridamole; Humans; Kinetics; Mass Spectrometry; Mopidamol; Platelet Activating Factor; Platelet Aggregation; Polymers; Povidone; Structure-Activity Relationship | 1987 |
Eosinophils isolated by magnetic cell sorting respond poorly to lipid chemoattractants.
Topics: Blood Donors; Chemotactic Factors; Chemotaxis; Dose-Response Relationship, Drug; Endothelium, Vascular; Eosinophils; Humans; Immunomagnetic Separation; Leukotriene B4; Platelet Activating Factor; Povidone; Silicon Dioxide; Umbilical Veins | 1999 |